Our latest Focus Issue looks at what we’ve learnt over the past decade and what’s next for the field of trained immunity.

Vaccines train the body's defenses to fight infections safely. Learn how vaccines work, how the immune system responds, and ...

Being born with two X chromosomes brings a host of health benefits, and recognising this could lead to personalised medical ...

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms ...

New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune ...

A French study in Cell Reports suggests vaccines could one day be delivered through a simple skin massage — no needles ...

Radiant Biotherapeutics to present new data from lead oncology programme at SITC 2025 annual meeting: Toronto Thursday, November 6, 2025, 18:00 Hrs [IST] Radiant Biotherapeutics, ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

-- RBT-101, Radiant's lead oncology program and 4-1BB agonist, demonstrated robust, durable and complete tumor regression without liver toxicity in MC38 colorectal mouse tumor model -- Poster ...

Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 ...

Radiant Biotherapeutics, a biotechnology company committed to advancing a breakthrough antibody approach, the Multabody™, for a broad range of therapeutic areas, including cancer and infectious ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q3 2025 Earnings Call Transcript November 13, 2025 ...